Primary hyperoxaluria type 2

General Information (adopted from Orphanet):

Synonyms, Signs: GLYCERIC ACIDURIA
OXALOSIS II
GLYOXYLATE REDUCTASE/HYDROXYPYRUVATE REDUCTASE DEFICIENCY
HP2
PH2
d-glycerate dehydrogenase deficiency
L-glyceric aciduria
Number of Symptoms 10
OrphanetNr: 93599
OMIM Id: 260000
ICD-10: E74.8
UMLs:
MeSH:
MedDRA:
Snomed:

Prevalence, inheritance and age of onset:

Prevalence: < 0.1 of 100 000
Inheritance:
Age of onset:

Disease classification (adopted from Orphanet):

Parent Diseases: Primary hyperoxaluria
 -Rare eye disease
 -Rare genetic disease
 -Rare renal disease

Comment:

Hyperoxaluria type II is associated with mutations in gene GRHPR (Glyoxylate reductase/hydroxypyruvate reductase. The most common mutation is c.103delG (PMID:20921818). Caucasians with PH2 should be screened for the c.103delG mutation; patients from the Indian subcontinent for c.494G>A; and patients of East Asian origin (particularly) for c.864_865delTG (PMID:24116921). Primary hyperoxaluria type 2 (PH2) is a less aggressive form of PH with better preservation of renal function and lower incidence of end stage renal disease and less severe nephrocalcinosis compared to PH1 (PMID:25949937). Median age at diagnosis was 1.7 years (PMID:25949937). The authors propose that all children presenting with nephrolithiasis secondary to hyperoxaluria should have urine glycerate measured (PMID:12185464).

Symptom Information: Sort by abundance 

1
(HPO:0000083) Renal insufficiency 25949937 IBIS 232 / 7739
2
(HPO:0003159) Hyperoxaluria Very frequent [IBIS] 12185464 IBIS 6 / 7739
3
(HPO:0012580) Calcium phosphate nephrolithiasis 12185464 IBIS 2 / 7739
4
(HPO:0008672) Calcium oxalate nephrolithiasis Frequent [IBIS] 12185464 IBIS 10 / 7739
5
(HPO:0000121) Nephrocalcinosis Occasional [IBIS] 12185464 IBIS 57 / 7739
6
(HPO:0000790) Hematuria Frequent [IBIS] 12185464 IBIS 106 / 7739
7
(HPO:0004354) Abnormality of carboxylic acid metabolism Very frequent [IBIS] 12185464 IBIS 1 / 7739
8
(MedDRA:10060033) Glyceric acid urine increased Very frequent [IBIS] 12185464 IBIS 1 / 7739
9
(OMIM) D-glycerate dehydrogenase deficiency 12185464 IBIS 1 / 7739
10
(OMIM) Glyceric aciduria 12185464 IBIS 1 / 7739

Associated genes:

GRHPR;

ClinVar (via SNiPA)

Gene symbol Variation Clinical significance Reference

Additional Information:

Clinical Description OMIM Williams and Smith (1971) presented evidence that in hyperoxaluria II, hydroxypyruvate, present in excess because of deficiency in the enzyme that converts it to D-glycerate, stimulates oxidation of glycolate to oxalate, and decreases reduction of glyoxylate to glycolate. ...
Molecular genetics OMIM Cramer et al. (1999) found homozygosity for an identical mutation in the GRHPR gene (604296.0001) in 2 pairs of sibs from unrelated families with type II primary hyperoxaluria.
Diagnosis GeneReviews Primary hyperoxaluria type 2 (PH2) is caused by deficiency of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR). ...
Clinical Description GeneReviews The age of onset of primary hyperoxaluria type 2 (PH2) is typically in childhood [Milliner et al 2001, Johnson et al 2002], with those diagnosed in later life often relating symptoms from childhood [Rumsby et al 2001, Takayama et al 2007]. As in PH1, establishing the diagnosis is often delayed, sometimes even for years....
Genotype-Phenotype Correlations GeneReviews The low prevalence of PH2 does not allow genotype-phenotype correlations at the present time. ...
Differential Diagnosis GeneReviews Stone disease. For any individual presenting with symptoms related to renal stone disease it is essential to analyze the stone if at all possible as this can help to direct the clinician to a particular line of investigation. The stones in individuals with PH2 are calcium oxalate....
Management GeneReviews To establish the extent of disease in an individual diagnosed with primary hyperoxaluria type 2 (PH2), the following evaluations are recommended [Leumann & Hoppe 2001]:...
Molecular genetics GeneReviews Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED....